Controller medications, also known as daily maintenance medications, are a critical tool for managing asthma — reducing daily ...

Airsupra (PT027), a new asthma rescue treatment developed by AstraZeneca (AZ) and development partner Avillion, has been approved by the US Food and Drug Administration (FDA). A first-in-class ...

This study highlights the benefits of anti-inflammatory inhalers in asthma management, showing reduced complications and ...

[1] All of these pathophysiologic features are largely represented in asthma, and therefore, anticholinergic drugs have been considered to be of potential interest in the treatment of asthma.

There is a need to develop new anti-inflammatory therapies for this disease. This article critically reviews clinical trial data of novel anti-inflammatory drugs in asthma, encompassing specific ...

Over 40 companies are working on more than 50 therapies for severe asthma. The severe asthma market is growing due to a ...

Researchers at National Jewish Health and colleagues have identified a mechanism involved in the formation of mucus plugs in ...

A study published in JAMA reports on data showing that Combination ICS-SABA and ICS-Formoterol asthma treatments are more effective than SAMA-only treatment. Details of the study were presented in ...

Upstream Bio garners analyst optimism for its lead drug verekitug, which could disrupt the $7.5 billion asthma biologics ...